TLX News: Telix and Xiel Sign U.K. and Ireland Distribution Agreement for Illuccix® - 29th Mar 2022, 10:39am

[annb0t]

MELBOURNE, Australia and LIÈGE, Belgium, March 29, 2022 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces it has signed an exclusive agreement with Xiel Limited (Xiel) for the distribution of Telix's prostate cancer investigational imaging product, Illuccix® (TLX591-CDx, Kit for the preparation of 68Ga-PSMA-11 injection) in the United Kingdom (U.K.) and the Republic of Ireland.

Under the terms of the agreement, Xiel, a specialist distributor of N...

>>> Read more: Telix and Xiel Sign U.K. and Ireland Distribution Agreement for Illuccix®